Vol 10, No 1 (February 01, 2021): Chinese Clinical Oncology

Review Article

Epidemiology, mutational landscape and staging of hepatocellular carcinoma
Sarah E. Fenton, Michael C. Burns, Aparna Kalyan
Chinese Clinical Oncology  
2021;
10
(1)
:2
.
 (01 February 2021) 
PDF Full Text (5539) COI Form Open Access Get Permission
Imaging diagnosis of hepatocellular carcinoma: LI-RADS
Guilherme Moura Cunha, Claude B. Sirlin, Kathryn J. Fowler
Chinese Clinical Oncology  
2021;
10
(1)
:3
.
 (01 February 2021) 
PDF Full Text (9838) COI Form Open Access Get Permission
The optimal timing and management of hepatitis B and C in patients with hepatocellular carcinoma
Thuy-Van P. Hang, Joel P. Wedd
Chinese Clinical Oncology  
2021;
10
(1)
:4
.
 (01 February 2021) 
PDF Full Text (9394) COI Form Open Access Get Permission
Surgical resection of early stage hepatocellular carcinoma: balancing tumor biology with the host liver
Michelle R. Ju, Adam C. Yopp
Chinese Clinical Oncology  
2021;
10
(1)
:5
.
 (01 February 2021) 
PDF Full Text (3915) COI Form Open Access Get Permission
Liver transplantation: expanding the donor and recipient pool
Ola Ahmed, M. B. Majella Doyle
Chinese Clinical Oncology  
2021;
10
(1)
:6
.
 (01 February 2021) 
PDF Full Text (4160) COI Form Open Access Get Permission
Neoadjuvant and adjuvant treatment approaches for hepatocellular carcinoma: future outlook
Ibrahim Halil Sahin, Lana Khalil, Ralph Millett, Ahmed Kaseb
Chinese Clinical Oncology  
2021;
10
(1)
:7
.
 (01 February 2021) 
PDF Full Text (4824) COI Form Open Access Get Permission
Liver-directed therapy for hepatocellular carcinoma
Cathal O’Leary, Mary Mahler, Michael C. Soulen
Chinese Clinical Oncology  
2021;
10
(1)
:8
.
 (01 February 2021) 
PDF Full Text (3897) COI Form Open Access Get Permission
Efficacy and safety of radiotherapy for primary liver cancer
Wenqi Chen, Chi-Leung Chiang, Laura A. Dawson
Chinese Clinical Oncology  
2021;
10
(1)
:9
.
 (01 February 2021) 
PDF Full Text (16316) COI Form Open Access Get Permission
Systemic therapy for advanced hepatocellular carcinoma: targeted therapies
Sri Harsha Tella, Anuhya Kommalapati, Amit Mahipal
Chinese Clinical Oncology  
2021;
10
(1)
:10
.
 (01 February 2021) 
PDF Full Text (3851) COI Form Open Access Get Permission
Immunotherapy and chimeric antigen receptor T-cell therapy in hepatocellular carcinoma
Pedro Luiz Serrano Uson Junior, Alex J. Liu, Mohamad Bassam Sonbol, Mitesh J. Borad, Tanios S. Bekaii-Saab
Chinese Clinical Oncology  
2021;
10
(1)
:11
.
 (01 February 2021) 
PDF Full Text (6466) COI Form Open Access Get Permission
Hepatocellular carcinoma, novel therapies on the horizon
Imane El Dika, Iman Makki, Ghassan K. Abou-Alfa
Chinese Clinical Oncology  
2021;
10
(1)
:12
.
 (01 February 2021) 
PDF Full Text (3604) COI Form Open Access Get Permission

Editorial

Hepatocellular carcinoma: current state and future horizons
Mehmet Akce, Shishir K. Maithel
Chinese Clinical Oncology  
2021;
10
(1)
:1
.
 (01 February 2021) 
PDF Full Text (1543) COI Form Open Access Get Permission